2025年4月15日 星期二
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2020, Vol. 26 Issue (8): 1291-1295    DOI: 10.3969/j.issn.1006-6233.2020.08.014
  论著 本期目录 | 过刊浏览 | 高级检索 |
miR-663b对低糖诱导的人椎间盘退变髓核细胞的细胞活性及凋亡的影响
王鹏, 左斌, 唐家国, 何精选, 何精选
长江航运总医院骨科, 湖北 武汉 430014
An Analysis of the Effects of MicroRNA-663b on Cell Activity and Apoptosis of Human Intervertebral Disc Degeneration Nucleus Pulposus Cells Induced by Low Glucose
WANG Peng, ZUO bin, TANG Jiaguo, et al
Changjiang Shipping General Hospital, Hubei Wuhan 430014, China
全文: PDF (1736 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的: 研究miR-663b对低糖诱导的人椎间盘退变髓核细胞增殖凋亡的调控机制。方法: 运用实时荧光定量反转录聚合酶链反应(qRT-PCR)实验检测人椎间盘退缩患者组织和葡萄糖(5、1 mmoL/L)处理的椎间盘退变髓核细胞中miR-663b的表达;脂质体法将低糖组+miR-NC组(转染miR-NC)、低糖组+miR-663b组(转染miR-663b mimics)、低糖组+anti-miR-NC组(转染anti-miR-NC)、低糖组+anti-miR-663b组(转染anti-miR-663b)转染至1 mmoL/L处理的椎间盘退变髓核细胞。细胞计数试剂盒(CCK-8)法、流式细胞术、免疫印迹(Western blot)检测细胞的吸光度(OD)值、细胞的凋亡率、细胞中细胞周期依赖性蛋白激酶抑制因子1A (P21)、半胱氨酸天冬氨酸蛋白酶(Caspase-3)的蛋白表达。结果: miR-663b在人椎间盘退缩患者组织和1 mmoL/L葡萄糖(低糖组)处理的椎间盘退变髓核细胞中的表达均明显降低(P<0.05)。低糖组细胞的增殖能力受到抑制, 凋亡能力得到提升, 并且P21和Caspase-3的蛋白表达量得到提升。过表达miR-663b的低糖组细胞中miR-663b表达明显升高, 细胞增殖能力也明显升高, 细胞凋亡能力则明显降低, P21和Caspase-3的蛋白表达量得到抑制, 而抑制miR-663b的低糖组细胞则发生相反的作用。结论: miR-663b可促进低糖诱导的人椎间盘退变髓核细胞的增殖, 抑制凋亡。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 miR-663b 人椎间盘退变髓核细胞 增 殖 凋 亡    
AbstractObjective: To study the regulatory mechanism of miR-663b on the proliferation and apoptosis of human intervertebral disc degeneration nucleus pulposus cells induced by low glucose. Methods: The expression of miR-663b in degenerative nucleus pulposus cells of human disc herniation and glucose (5, 1 mmol/L) -treated discs was detected by real-time fluorescent quantitative reverse transcription polymerase chain reaction (qRT-PCR) experiments. The low glucose group + miR-NC group (transfected with miR-NC), the low glucose group + miR-663b group (transfected with miR-663b mimics), and the low glucose group + anti-miR-NC group (transfected with anti-miR -NC), low glucose group + anti-miR-663b group (transfected with anti-miR-663b), divided with the plastid method, were transfected into 1 mmol/L treated disc degeneration nucleus pulposus cells. Cell Counting Kit (CCK-8) method, flow cytometry, and western blot were used to detect the absorbance (OD) value of cells, the apoptosis rate of cells, and cell cycle-dependent protein kinase inhibitor 1A (P21) , protein expression of cysteine aspartic protease (Caspase-3) in cells. Results: The expression of miR-663b in tissues of human disc herniation and 1 mmol/L glucose (low glucose group) treated disc degeneration nucleus pulposus cells were significantly reduced (P<0.05). The cells of the low glucose group were inhibited from proliferating, their apoptotic capacity was improved, and the protein expression of P21 and Caspase-3 was increased. The expression of miR-663b was significantly increased in the low-glucose group cells overexpressing miR-663b, the cell proliferation ability was also significantly increased, and the apoptotic capacity was significantly reduced. The protein expression levels of P21 and Caspase-3 were inhibited, while miR-663b's low-glucose group cells had opposite effect. Conclusion: MiR-663b can promote the proliferation of human intervertebral disc degeneration nucleus pulposus cells induced by low glucose and inhibit apoptosis.
Key wordsMiR-663b    Human intervertebral disc degeneration nucleus pulposus cells    Proliferation    Apoptosis
    
基金资助:湖北省卫生计生委科研项目, (编号:WJ2019H388)
通讯作者: 何精选   
引用本文:   
王鹏, 左斌, 唐家国, 何精选, 何精选. miR-663b对低糖诱导的人椎间盘退变髓核细胞的细胞活性及凋亡的影响[J]. 河北医学, 2020, 26(8): 1291-1295.
WANG Peng, ZUO bin, TANG Jiaguo, et al. An Analysis of the Effects of MicroRNA-663b on Cell Activity and Apoptosis of Human Intervertebral Disc Degeneration Nucleus Pulposus Cells Induced by Low Glucose. HeBei Med, 2020, 26(8): 1291-1295.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2020.08.014     或     http://www.hbyxzzs.cn/CN/Y2020/V26/I8/1291
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发